TNFSF10 and glioma: Siegelin et al. showed that 24-h treatment of U87 and A172 cells with 20 mM EGCG resulted in a significative reduction in both survivin and PEA15 levels, through sensitization of TRAIL-resistant glioma cells to TRAIL treatment.